Next Article in Journal
Nitrosyl and Thionitrosyl Complexes of Technetium and Rhenium and Their Reactions with Hydrotris(pyrazolyl)borates
Previous Article in Journal
An Examination of Chemical Tools for Hydrogen Selenide Donation and Detection
Previous Article in Special Issue
Synthesis and Anti-Trypanosoma cruzi Activity of New Pyrazole-Thiadiazole Scaffolds
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 29
Issue 16
10.3390/molecules29163864
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Diverse Methods with Stereoselective Induction in the Asymmetric Biginelli Reaction

by
Marcos Díaz-Fernández
1,2,
Manuel Algarra
3,
Saturnino Calvo-Losada
2,
José-Joaquín Quirante
2,
Francisco Sarabia
1 and
María-Soledad Pino-González
1,*
1
Department of Organic Chemistry, Faculty of Sciences, University of Málaga, 29071 Málaga, Spain
2
Department of Physical Chemistry, Faculty of Sciences, University of Málaga, 29071 Málaga, Spain
3
Department of Science, INAMAT2-Institute for Advanced Materials and Mathematics, Public University of Navarra, 31006 Pamplona, Spain
*
Author to whom correspondence should be addressed.
Molecules 2024, 29(16), 3864; https://doi.org/10.3390/molecules29163864
Submission received: 30 May 2024 / Revised: 21 July 2024 / Accepted: 26 July 2024 / Published: 15 August 2024
(This article belongs to the Special Issue Heterocyclic Compounds for Drug Design and Drug Discovery)
Browse Figures
Versions Notes

Abstract

:
The relevance of the asymmetric Biginelli reaction (ABR) has been increased in this century, due to the pharmacological application of its products. This review focuses predominantly on articles published in the period from 2015 to 2024 on asymmetric synthetic advances in the formation of dihydropyrimidinones (DHPMs), dihydropyrimidinethiones (DHPMTs), and related compounds. The relevant bibliography on general processes in the Biginelli reaction and some methods of separation of isomers have also been referenced.

1. Introduction

Among the multicomponent reactions (MCRs) [1], one of the most studied since its discovery in 1891 is the Biginelli reaction [2,3], which produces dihydropyrimidines (DHPMs) as the main application. A large number of procedures have been published varying the type of starting compounds, catalysts, and solvents, emphasizing the variety of applications of their products [4]. Most of the procedures emphasized the importance of obtaining good reaction yields and optimal conditions. To attain these goals, the mechanism of the Biginelli reaction has been considered in several publications [5,6]. Given the pharmacological importance of Biginelli products [7,8], structure–activity correlation studies have been reported, but in a large number of cases, the studies have been carried out on racemic mixtures [9,10]. Recently, considering that in some structures one of the enantiomers might have a high biological activity and not the other (or even the opposite activity), the importance of obtaining enantiomerically pure DHPMs has been highlighted [11,12]. As a consequence, obtaining enantiomerically pure DHPMs has become a synthetic priority. Another possibility that has been explored is the separation of both enantiomers from their racemic mixtures. With that purpose, Kappe et al. performed chiral enantiomer resolution via the fractional crystallization of diastereomeric salts [13]. Blasco et al. reported a biocatalytic highly enantioselective synthesis of (S)-monastrol via enzymatic resolution. These authors utilized lipase enzyme to afford the (R) enantiomer in 48% yield (66% ee) and (S) in 31% yield (97% ee) [14]. More recently, a redox deracemization of 3,4-dihydropyrimidin-2-ones with phosphonate substituents at the C4-position has been performed, obtaining optically active DHPMs derivatives [15]. In another work, racemic ligands were separated by semipreparative HPLC on a chiral stationary phase. The obtained DHPMs were studied as antagonists of the human A2B adenosine receptor [16]. The studies were developed considering structure–activity relationship and enantioselective recognition. In some examples, the (S) stereoisomer was shown to be almost twice as potent than the racemic mixture. Other published methods were based on the asymmetric reduction of 2-hydroxypyrimidines and H-substituted pyrimidin-2-ones [17,18]. In addition, with the aim of obtaining information on the individual capabilities of an enantiomer (in their application as potential pharmaceuticals), theoretical calculations have been carried out on specific DHPMs. Nonetheless, a non-asymmetric Biginelli route was utilized [19].
In addition to the Biginelli reaction, other methods have been published to stereoselectively obtain DHPMs, such as those involving cycloaddition reactions. Thus, in a review published by our group on this type of reaction, in the synthesis of DHPMs and related compounds, some stereoselective reactions of DHPMS have been described [20].
Chronologically speaking, the publication of studies on Biginelli asymmetric synthesis started off at the turn of the century. Thus, we can consider the pioneering work of Juaristi and Muñoz-Muñiz in 2003, using a chiral amide with CeCl3 and InCl3. However, only up to 40% ee was obtained [21]. Subsequently, Zhu and co-workers, in 2005 [22], described a more efficient enantioselective Biginelli reaction, reaching an ee superior to 99%, using a new chiral ytterbium catalyst. Later on, Gong’s research group reported the use of 1,1’-bi-2-naphthol (BINOL)-derived chiral phosphoric acids as organocatalysts, furnishing the DHPMs with up to 97% ee [23] Subsequently, in 2009, this group found out that the stereochemistry of the reaction could be reversed by adjusting the size of the 3,3′-disubstituents of the binaphthol phosphoric acids [24].
In this review, we will focus on the asymmetric Biginelli reactions that allow us to directly obtain the enantiomerically pure products. The publications carried out from 2015 to the beginning of 2024 will be preferentially taken into account. In the last few years, other review papers with information on ABRs have been published [1,4,12]. Even during the process of finalizing this manuscript, a new review has been reported [25] highlighting the current importance of ABRs in organic synthesis.

2. Strategies in the Asymmetric Biginelli Reactions

With the aim of obtaining enantiopure DHPs, several strategies have been carried out with the use of different types of catalysts.

2.1. Synthetic Chiral Organic Catalysts

In recent years, the Biginelli asymmetric reaction with synthetic chiral organic catalysts has been the most relevant method to obtain enantiopure DHPMs [12,25].

2.1.1. Chiral Brønsted Acids

Phosphoric Acids

In the last twenty years, apart from ABRs, there has been a profusion of methods with chiral phosphoric acid for catalyzed asymmetric multicomponent reactions [26]. Surprisingly, highly enantioselective reactions could be observed by using non-optically pure phosphoric acids [27]. A derivative of L-tartaric acid was the choice by Hu et al. [28] to design a novel sterically hindered chiral cyclic phosphoric acid cat Ia. Its synthesis was based on a highly regioselective protection of hydroxyls 1 and 4 of chiral (R,R) 1,1,4,4-tetraphenylbutanetetraol. Good enantioselectivities were obtained by this asymmetric Biginelli reaction (up to 99% ee, see Scheme 1) [28].
Lately (in 2020, [29]), the latter research group proposed a plausible chiral transition-state structure in the Biginelli-like reaction catalyzed by the phosphoric acid cat Ia, with cyclohexanone as an enolizable compound, to obtain the bicyclic asymmetric pyrimidines 5 (Scheme 2). In this model, the chiral cat Ia activates the intermediate imine. The two hydroxyl groups form intramolecular and intermolecular H-bonds with the enolizable ketone, favoring the stereoselective attack of the enol on the imine. When the methoxy derivative cat Ib was used as a catalyst, the enantiomeric excess was lower, indicating that the two hydroxyl groups were indispensable for attaining a higher enantioselectivity (Scheme 2).
Aliphatic aldehydes have also been catalyzed by chiral phosphoric acids in an ABR. Precisely, Guo et al. designed a synthetic strategy to obtain the bicyclic guanidine core 7 of Crambescin A and Batzelladine A in the presence of the catalyst cat II (see Scheme 3 and Figure 1) [30,31]. Thus, Crambescin A could be synthesized according to previously reported literature procedures [32]. Lately, a synthesis of (+)-Crambescin A was reported by Guo’s group, but without employing the Biginelli reaction [33].
The spirocyclic phosphoric acid cat III was used in another asymmetric reaction to obtain 4-alkyl-3,4-dihydropyrimidin-2-(1H)-one (4-alkyl-DHPM) scaffolds with good yields and enantioselectivity (Scheme 4). Subsequent studies showed that this strategy was optimal for the synthesis of the structural core of Batzelladine A. Thus, this procedure [34] improved the results reported in the literature [32], providing the bicyclic guanidine fragment of (+)-Batzelladine A 9 in only 6 steps and 22% of total yield (compared to previous 12 steps and 13% of total yield, see Scheme 5) [32].
On the other hand, taking into account that the chiral 6-isopropyldihydropyrimidines 11 are very important intermediates for statin drugs, an organocatalyzed ABR was designed [35]. The chiral BINOL-derived phosphoric acid cat IVa catalyzed the condensation of aromatic aldehydes, β-dicarbonyl compounds 10, and thiourea, in the asymmetric synthesis of 6-isopropyl-3,4-dihydropyrimidines 11 obtained with good yields and enantioselectivities (Scheme 6). Recently, Chetty et al. in 2024 [36], studying the optimal solvent conditions for obtaining 11, carried out the enantioselective reaction of nitrobenzaldehyde, acetoacetate, and thiourea in the presence of silylated cat IVb, (Scheme 6). It was shown that both toluene and cyclopentyl methyl ether gave equivalent results in both cases (99% yield and 92% ee).
The ability of isatin to form part of various anticancer pharmacophores has been recently reviewed, highlighting its effectiveness in Biginelli-like reactions [37]. As a matter of fact, isatins act as carbonyl substrates in this type of reaction. Thus, an asymmetric Brønsted acid-catalyzed Biginelli-like reaction was reported, employing the N-substituted isatins 12, urea, and alkyl acetoacetates. The BINOL-derived phosphoric acid cat IVa catalyzed the enantioselective formation of a small library of chiral, spiro(indoline-pyrimidine) dione derivatives 13 (Scheme 7). The absolute configuration of the new spiro stereocenter was assigned based on NMR studies of diastereomeric derivatives [38].
Other series of spirooxindole-dihydropyrimidinones and -dihydropyrimidinethiones with analogous structures to that of 13 were described by Maddela et al. who utilized Fe3O4 nanoparticles as a catalyst [39].

Sulfonic Acids and Derivatives

Barbero et al. [40] reported the use of a derivative of 1,2-benzenedisulfonimide as a chiral Brønsted catalyst (cat V) for ABRs. These authors used different reagents (aromatic aldehydes, urea or thiourea and ethyl acetoacetate) and 5 mol% of the catalyst cat V under neat conditions and heating at 50 °C. High yields of DHPMs (average 91%) and enantiomeric excesses (average 97%) were achieved. In addition, they proposed a mechanism for the enantioselective formation of the DHPMs 4 with cat V (Scheme 8).
In 2023, Nasery et al. [41] reported a sulfonic-functionalized hyperbranched polylysine (HBPL-SO3H) (cat VI) as a novel and efficient organocatalyst in an asymmetric Biginelli reaction (Figure 2). All of the reactions were carried out with 1 mmol of aryl aldehyde, urea or thiourea, ethyl or methyl acetoacetate, and 0.03 g of HBPL-SO3H, under solvent-free conditions (70 °C, 7 h). The chiral dihydropyrimidinones 14 were obtained in 83–97% yield and 70–98% ee (determined by chiral HPLC analysis) (Scheme 9). HBPL-SO3H was synthesized in 98% yield, its structure was confirmed by IR, NMR, XRD, and TGA analyses, and it could be reused.

2.1.2. Ionic Liquids with Chiral Organic Framework

The relevance of the role of ionic liquids (ILs) in the Biginelli reaction, alone or in combination with homogeneous and heterogeneous catalysts, is well established [42]. In the last few years, chiral ionic liquid catalysts have also been studied in relation to their role in asymmetric reactions [42].
In 2018, Alvim et al. [43] studied the ionic liquid effect (ILE) combined with an asymmetric counteranion-directed catalysis (ACDC) in an ABR. Ionic liquids bearing chiral anions were chosen as catalysts for enantioselective Biginelli reactions (Scheme 10). The reaction mechanism (via iminium) was elucidated using electrospray (tandem) mass spectrometry (ESI-MS/MS). Chiral induction arises from a supramolecular aggregate where the anion and the cation of the catalyst [MSI-(R)-TRIP] (cat VII) are alongside a key cationic intermediate of the reaction, with each component being essential for the chiral induction success. The resulting enantiomeric excesses of the THPMs 14 were measured by chiral HPLC analyses. The absolute stereochemistry of one THPM was confirmed with the literature data, and only the (R) isomer was formed (Scheme 10) [43].
Deepa et al. in 2022 [44] also used imidazolium ionic liquids in an ABR, but with adamantyl (L)-prolinamide and [BF4]− as the anion (cat VIII) and p-toluenesulfonic acid as an additive (see Scheme 11). A series of 30 chiral DHPMs were obtained in 16–74% yields and up to 85% ee (25 °C, 48 h). A feasible reaction mechanism and transition states or intermediates were proposed and supported by FT-NMR spectroscopy and DFT calculations. Thus, these studies showed a favored re-face attack on the imine bond, giving the (R)-configuration by asymmetric induction.

2.1.3. Chiral Amines as Catalysts

As a matter of fact, numerous chiral organocatalysts in ABRs are amine compounds. Already in the early 2010s, a chiral primary amine catalyst was used by Xu et al. [45]. On the other hand, amines derived from cinchona alkaloids were assessed as organocatalysts for ABRs by Ding and Zhao, who proposed a feasible transition state for the formation of the obtained (R)-enantiomer (up to 78% ee) [46]. In 2016, Saá’s research group [47,48] obtained DHPMs with excellent enantioselectivities by asymmetric reaction with chiral catalysts (cat IX). Considering the via-imine mechanism for the Biginelli reaction, ten arylideneureas 15 were previously synthesized and later condensed with ethyl acetoacetate. Taking into account the mechanisms of biocatalysts, these authors chose these arylideneureas 15, which could act as donor-acceptors forming a network of cooperative hydrogen bonds (NCHB) with chiral amines (R,R)-I or (S,S)-I as organocatalysts (Scheme 12 and Figure 3). Acid treatment afforded the (R)-DHPMs 4a in good yields and enantioselectivities (Scheme 12). Similarly, in the second publication [48], the direct combination of an α-ureidosulfone 14 with an alkyl β-ketoester in the presence of a suitable organic base and the organocatalyst was carried out. The treatment of the crude Mannich mixture with acid led to DHPMs (S)-4a (Figure 3), while organic base (TMG) treatment yielded hexahydropyrimidinones (HHPMs) 16 (Scheme 13). It is worth noting the formation of three chiral centers in these HHPMs 16, which could be isolated without dehydration.
High enantioselectivity was achieved using a primary amine with an amide backbone as a chiral catalyst. Some authors studied the origin of the observed enantioselectivity by using density functional theory (DFT). The rate-determining step was the proton transfer process in the cyclization of the substrate, mediated by the amide moiety of the catalyst. These authors concluded that the orientation of the amide moiety was the determinant fact for the observed enantioselectivity [49].
Proline derivatives and analogues also represent appropriate options to achieve enantiomerically pure products in asymmetric Biginelli reactions. In 2015, Titova et al. [50] continued the use of amides of proline previously reported by Saha and Moorthy, who built a sterically hindered catalyst in 2012 (Figure 4), which rendered high selectivities [51]. In addition to modified prolines, menthol derivatives were employed in the new experiments [50]. These chiral molecules were immobilized on the surface of mixed nanoparticles of titanium and silicon oxides (TiO2·SiO2) containing (3-aminopropyl)triethoxysilane. The mixtures produced idoneous catalysts to promote chiral adducts increasing the selectivity observed in the ABR (Scheme 14) [50].
New experiments were carried out by the same group [52] combining another chiral proline-TFA derivative organocatalyst cat XV with titanium dioxide or alumina as heterogeneous catalysts. These additives were incorporated singly or mixed, in bulk or in nanosized form. Variations over reaction conditions were studied in addition to the role of the components, catalysts, and additives. A plausible transition state of the asymmetric reaction was also proposed (see Scheme 15).
Prolinamides were found to be better catalysts in asymmetric organic reactions compared to proline in most cases [53]. Thus, prolinamide derivatives of 4-Hydroxy-(2S)-prolines bearing 1,2,3,4-tetrahydroquinoline or 3,4-dihydro-2H-1,4-benzoxazine or diverse substituents were synthesized and treated with nanosized oxides SiO2·ZrO2 to eventually use these combinations as heterogeneous chiral catalysts in an ABR [54]. An increase in the ee values of the reaction product was observed when nanoparticles of SiO2·ZrO2 were added to the chiral proline derivatives cat XVI or cat XVII (Figure 5), from 54% (without oxides) up to 76%.
A variation of this methodology by these authors consisted of the incorporation of a polyether spacer in the (2S,4R)-hydroxyproline derivative cat XVIII [55], allowing the authors to enhance the effect on the enantioselectivity of the Biginelli reaction by a factor of five. The best results were achieved for salts of these podands with trifluoroacetic acid (Figure 6).
The methodology was extended by using a variety of nanosized metal oxides (NiO, Fe3O4, CuO, Al2O3, SiO2, and TiO2·SiO2) [56]. The dihydropyrimidinethione-containing podand (R,R)-17 (Figure 7) was synthesized by an asymmetric Biginelli-like reaction. The best result was achieved in the presence of nanooxide of NiO and 4-hydroxy-L-proline under mild conditions (70% ee and a moderate yield). Related experiments reported by these authors encompassed metal salts (especially metal nitrates) as additives, to study plausible complexes’ formation in the transition states (Figure 8) [57]. In another publication, it was shown that the combined system L-proline/SiO2·Mg(OH)2 as a catalyst led to an enhanced enantiomeric excess of some ABR products of up to 18% [58]. The ee values were determined by high-efficiency liquid chromatography.
With the aim of testing the effects of chiral inductors based on 4-hydroxy-L-proline podands (Figure 6, n = 2) on the selectivity of ABR, a theoretical study was performed [59]. The results showed that when the podand was in a base form, the interaction of a podand–acetoacetate adduct with N-benzylideneurea was preferred, while for a salt form, the interaction with benzaldehyde was more favorable (via iminium), which led to a higher stereoselectivity.
Very recently, a new work has been published by this group [60]. This work showed the relevant role of the hydroxyl group of the chiral inductor cat (S,S)-XIXb (based on trans-4-hydroxyproline) in obtaining the target podand 17, enriched with the (R,R)-enantiomer. Considering the iminium mechanism, the hydroxyl group promotes the prochiral Si-face of the Schiff base with a maximum of 75% ee (Scheme 16). It should be noted that a known hydroxyphenyl analogue of 17 inhibits the activity of the motor protein Eg5.

2.1.4. Other Chiral Organic Catalysts

A number of asymmetric multicomponent reactions are catalyzed by thiourea-based organocatalysts. Thus, in ABRs, chiral organic compounds possessing a thiourea skeleton have been shown to be useful in the enantioselective formation of dihydropyrimidine thiones [61]. Early work was reported with a bifunctional primary amine, with TfOH as a chiral phase-transfer catalyst, and with t-BuNH2·TFA as an additive, showing moderate enantioselectivities [62]. Good examples are the syntheses depicted in Scheme 17. A series of α,β-unsaturated aldehydes 20 and various β-ketoesters 21 reacted in an ABR catalyzed by a proline/thiourea-based dual system (cat XX) [63,64]. Preliminary studies [63] were carried out with methyl or ethyl isobutyrylacetate in various solvents and different catalyst mixtures of prolines and thioureas, to find the optimum reaction conditions. The best results for the DHPTs 22 were obtained with the proline 23a (5 mol%)/thiourea 24a (5 mol%), providing excellent yields (90–96%) and high enantioselectivities (92–99% ee) [64]. A plausible transition state was proposed to explain the observed asymmetric induction. The role of the H-bonding, involved in the process, appeared to be crucial in the formation of the transition state (Scheme 18).

Organocatalyst with Metallic Cations

A variety of organocatalysts can form complexes with metallic cations in Biginelli reactions. Metallic complexes have been employed for some time in MCRs. In 2015, Kamali reported [65] an enantioselective synthesis of the dihydropyrimidines 4 using the chiral Schiff base copper (II) complex cat XXI as a chiral catalyst. The participation of cat XXI in an ABR allowed the obtainment of the (S) enantiomers of 3,4-dihydropyrimidine-2-ones (S)-4 (X=O) and their sulfur analogs 3,4-dihydropyrimidine-2-thiones (S)-4 (X=S) (Scheme 19).
Another Cu(II)–salen complex (cat XXII) encapsulated in MWW-zeolite framework pores showed its efficiency as an chiral organocatalyst in the enantioselective formation of the DHPMs derivatives (R)-4 (Scheme 20) [66]. The structural properties of cat XXII were confirmed by spectroscopic methods. In addition, computer-assisted DFT calculations were essential to study the process (Scheme 20).

Boranes

Chiral binol borane has been used as a Lewis acid catalyst in ABRs. For instance, the reaction of the 5-Bromo-2-acyl salicylaldehyde 25 with ethyl acetoacetate and urea using cat XXIII in THF led to a bromopyrimidine 26 [67]. The absolute configuration of a single crystal (S)-26 was determined by X-ray (Scheme 21).

2.1.5. Biocatalysts

Several ABRs using biocatalysts have been described in the last few years. For example, in 2013, bovine serum albumin (BSA) was chosen as a natural catalyst, allowing for a gram-scale synthesis of Monastrol, even though selectivities were not good [68]. Later, in 2022, Elkanzi et al. [69] carried out a Biginelli reaction in the presence of cysteine as a new green bio-organic catalyst. Although the catalyst was chiral, the authors did not provide any data on enantioselectivity. Nevertheless, they performed docking studies on certain enantiomers such as (S)-28 (Scheme 22). All compounds were studied by molecular docking and subsequently their antifungal activities were evaluated.
In a recent work [70], taurine showed its efficiency as a green and reusable bio-organic catalyst (up to 99% yield). In fact, this is not an example of asymmetric reaction, but we highlight it as a current example of efficient enantiomer separation. Chiral resolution of the twenty-three derivatives of the (R/S)-THPM-5-carboxanilides 30 was carried out by chiral HPLC (up to 99.99% purity). The absolute configuration of all the enantiomerically pure isomers was determined using a circular dichroism study and validated by a computational approach (Scheme 23).

2.1.6. Chiral Starting Compounds

In addition to using chiral catalysts to achieve ABRs with good stereoselectivity, it is possible to perform asymmetric induction starting from chiral compounds. In the last few years, research studies have been carried out on formyl monosaccharide derivatives to achieve optically active DHPMs [71]. One single stereoisomer with the (R)-configuration was isolated. Recently [72], a novel Biginelli reaction utilized as an acetylacetate derivative an ester of ursodeoxycholic acid (UDCA), which is present in the human intestine and with the possible application that their hybrids could be potential therapeutic agents. Surprisingly, the chiral skeleton of the ester 31 did not perform sufficient chiral induction to selectively obtain one of the isomers. The diastereomeric DHPMs 32 were obtained in a 1:1 ratio with 70% yield (Scheme 24).
Myrtenal was used as a chiral aldehydic substrate to produce a valuable asymmetric induction in the synthesis of THPMs [73]. To a mixture of ethyl acetoacetate and urea in ethyl lactate as a green solvent, (1R)-(−)-myrtenal was added. The result, after heating, was the formation of the isomer (4R)-33 as a white solid (Scheme 25). The authors highlighted the role of the chiral green solvent in combination with myrtenal to achieve the optimal diastereoselectivity. The product was characterized by several spectroscopic methods, and its structure was determined by X-ray crystallography.

2.1.7. Nanoparticles as Catalyst Support

A number of works on Biginelli-catalyzed reactions in the presence of NPs have already been referenced [39,50,54,56]. In 2019, Jafari-Chermahini et al. reported the preparation of functionalized NPs from magnetite by successive application of blended natural polymers (gelatin and λ–carrageenan) on an Fe3O4 core [74]. It was studied the role of Gelatin as enantiomeric inductor in the catalytic active sites. On the other side, λ–carrageenan provides stability for gelatin immobilization on Fe3O4 nanoparticles. The amino acid sites, presented at the surface of the NPs, showed their efficiency as organocatalysts for ABRs. The corresponding DHPMs were obtained in good to excellent yields with 63–98% ee.

2.1.8. Biginelli Related Reactions

Spirofuranes

A variety of spirofuran-hydropyrimidinone or -hydropyrimidinethione compounds 35 were prepared from the alkynols 34 [75]. These compounds served as enolizable carbonyl equivalents to react with urea or thiourea and aromatic aldehydes, with co-catalysis of palladium chloride and trifluoroacetic acid, giving good yields and trans stereoselectivity An asymmetric version was carried out for Ar = p-chlorophenyl, with catalysis of Pd(OAc)2 and the chiral phosphoric acid cat XXIII, but 35 was obtained in only 33% yield and 11% ee (Scheme 26). In this case the results were not good, but the compound 35 could be useful given that it exhibits two asymmetric carbons.

Thiadiazine Derivatives

Although the following reaction is not actually a synthesis of THPMs, we highlight it as being related to the Biginelli reaction and its potential as an asymmetric reaction. Krauskopf et al. [76] valued the stereogenic sulphur in sulfonimidamides to obtain the diastereoisomers 37 with variable selectivities. For example, the NH-free sulfonimidamides 36 provided the 2,3-dihydro-1,2,6-thiadiazine 1-oxides 37 in high yields by using acetic acid or ytterbium triflate as catalysts. The couplings were performed in a planetary ball mill (PM) under solvent-free mechanochemical conditions. The structure of one of the products was characterized by X-ray single crystal structure analysis (Scheme 27).

3. Conclusions

Over the last few years, there has been an important increase in the publication of asymmetric methods. There is a growing awareness of the need to stereoselectively obtain the correct isomer, especially in applications for pharmaceuticals. Unfortunately, some authors do not provide enough information about the configuration obtained when they carry out a potential ABR. Among the catalysts described in asymmetric syntheses, the organocatalysts have proven more useful. Research has been carried out not only in the search for new Brønsted catalysts, but also for chiral amine and chiral amide derivatives as well. Ionic liquids have also been shown to be useful in combination with chiral molecules. On the other hand, in addition to the use of chiral catalysts, the use of chiral substrates to perform internal asymmetric induction should also be highlighted (unfortunately with few examples in this field). Some naturally occurring molecules such as monosaccharides, amino acids, and other chiral derivatives should be studied as starting materials, particularly in the case of monosaccharides (with scarce recent literature on ABRs), whose structures can be modified in numerous ways for eventually improving asymmetric induction.

Author Contributions

Conceptualization, M.-S.P.-G.; methodology, M.-S.P.-G. and M.A.; writing—review and editing, M.-S.P.-G., M.A., S.C.-L., M.D.-F., F.S. and J.-J.Q.; supervision, M.-S.P.-G. and M.A.; project administration, M.-S.P.-G. All authors have read and agreed to the published version of the manuscript.

Funding

Financial support has been received from the Spanish Ministry of Science and Innovation RTI2018-098296-BI00 (MINECO and FEDER), and M. Algarra would like to thank the Ministry of Science and Innovation (MCIN/AEI/https://doi.org/10.13039/501100011033) for their support under the grant number PID2021-122613OB-I00.

Data Availability Statement

No data are available.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Acronyms and Abbreviations

ABRAsymmetric Biginelli reaction
ACDCAsymmetric counteranion-directed catalysis
ILEIonic liquid effect
BINOL1,1′-bi-2-naphthol
DHPMsDihydropyrimidinones
DHPMTDihydropyrimidinethiones
DIPEADiisopropylethylamine
DMFDimethylformamide
drDiastereomer relation
eeEnantiomeric excess
HHPMHexahydropyrimidinones
MCRsMulticomponent reactions
MSMass spectroscopy
MSI1-Methyl-3-(3-sulfopropyl)-1H-imidazol-3-ium
NCHBNetwork of cooperative hydrogen bonds
NPNanoparticle
MWMicrowave
PMPlanetary ball mill
PTSAp-Toluenesulfonic acid
ProProline
rtRoom temperature
refReference
USUltrasound
TBTU2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethylaminium tetrafluoroborate
THFTetrahydrofuran
THPMsTetrahydropyrimidines
TMG1,1,3,3-Tetramethylguanidine
TFATrifluoroacetic acid
TMSClTrimethylsilane chloride
TRIP(R)-3,3′-Bis-(2,4,6-triisopropylphenyl)-1,1′-binaphthyl-2,2′-diyl phosphate

References

  1. Ramos, L.M.; Rodrigues, M.O.; Neto, B.A.D. Mechanistic knowledge and noncovalent interactions as the key features for enantioselective catalysed multicomponent reactions: A critical review. Org. Biomol. Chem. 2019, 17, 7260–7269. [Google Scholar] [CrossRef] [PubMed]
  2. Biginelli, P. Aldehyde-urea derivatives of aceto- and oxaloacetic acids. Gazz. Chim. Ital. 1893, 23, 360–416. [Google Scholar]
  3. Tron, G.C.; Minassi, A.; Appendino, G. Pietro Biginelli: The man behind the reaction. Eur. J. Org. Chem. 2011, 2011, 5541–5550. [Google Scholar] [CrossRef]
  4. Nagarajaiah, H.; Mukhopadhyay, A.; Moorthy, J.N. Biginelli reaction: An overview. Tetrahedron Lett. 2016, 57, 5135–5149. [Google Scholar] [CrossRef]
  5. Puripat, M.; Ramozzi, R.; Hatanaka, M.; Parasuk, W.; Parasuk, V.; Morokuma, K. The Biginelli reaction is a urea-catalyzed Organocatalytic Multicomponent Reaction. J. Org. Chem. 2015, 80, 6959–6967. [Google Scholar] [CrossRef]
  6. Kappe, C.O. A reexamination of the mechanism of the Biginelli dihydropyrimidine synthesis. Support for an N-acyliminium ion intermediate. J. Org. Chem. 1997, 62, 7201–7204. [Google Scholar] [CrossRef]
  7. Khasimbi, S.; Ali, F.; Manda, K.; Sharma, A.; Chauhan, G.; Wakode, S. Dihydropyrimidinones Scaffold as a Promising Nucleus for Synthetic Profile and Various Therapeutic Targets: A Review. Curr. Org. Synth. 2021, 18, 270–293. [Google Scholar] [CrossRef]
  8. Kappe, C.O. Biologically active dihydropyrimidones of the Biginelli–type–a literature survey. Eur. J. Med. Chem. 2000, 35, 1043–1052. [Google Scholar] [CrossRef]
  9. Carreiro, E.P.; Sena, A.M.; Puerta, A.; Padrón, J.M.; Burke, A.J. Synthesis of Novel 1,2,3-Triazole-Dihydropyrimidinone Hybrids Using Multicomponent 1,3-Dipolar Cycloaddition (Click)–Biginelli Reactions: Anticancer Activity. Synlett. 2020, 31, 615–621. [Google Scholar] [CrossRef]
  10. Prasad, T.; Mahapatra, A.; Sharma, T.; Sahoo, C.R.; Padhy, R.N. Dihydropyrimidinones as potent anticancer agents: Insight into the structure–activity relationship. Arch. Pharm. 2023, 356, e2200664. [Google Scholar] [CrossRef] [PubMed]
  11. Heravi, M.M.; Asadi, S.; Lashkariani, B.M. Recent progress in asymmetric Biginelli reaction. Mol. Divers. 2013, 17, 389–407. [Google Scholar] [CrossRef]
  12. Heravi, M.M.; Moradi, R.; Mohammadkhani, L.; Moradi, B. Current progress in asymmetric Biginelli reaction: An update. Mol. Divers. 2018, 22, 751–767. [Google Scholar] [CrossRef]
  13. Kappe, C.O.; Uray, G.; Roschger, P.; Lindner, W.; Kratky, C.; Keller, W. Synthesis, and reactions of Biginelli compounds –5. Facile preparation and resolution of a stable 5-dihydropyrimidinecarboxylic acid. Tetrahedron 1992, 48, 5473–5480. [Google Scholar] [CrossRef]
  14. Blasco, M.A.; Thumann, S.; Wittmann, J.; Giannis, A.; Gröger, H. Enantioselective biocatalytic synthesis of (S)-monastrol. Bioorg. Med. Chem. Lett. 2010, 20, 4679–4682. [Google Scholar] [CrossRef]
  15. Meng, F.-J.; Shao, B.-R.; Velopolcek, M.K.; Guo, X.; Feng, G.-S.; Shi, L. Redox deracemization of phosphonate-substituted dihydropyrimidines. Org. Biomol. Chem. 2021, 19, 10570–10574. [Google Scholar] [CrossRef]
  16. Majellaro, M.; Jespers, W.; Crespo, A.; Núñez, M.J.; Novio, S.; Azuaje, J.; Prieto-Díaz, R.; Gioé, C.; Alispahic, B.; Brea, J.; et al. 3, 4-Dihydropyrimidin-2 (1 H)-ones as antagonists of the human A2B Adenosine receptor: Optimization, structure–activity relationship studies, and enantiospecific recognition. J. Med. Chem. 2021, 64, 458–480. [Google Scholar] [CrossRef]
  17. Feng, G.-S.; Chen, M.-W.; Shi, L.; Zhou, Y.-G. Facile synthesis of chiral cyclic ureas through hydrogenation of 2-hydroxypyrimidine/pyrimidin-2(1H)-one tautomers. Angew. Chem. Int. Ed. Engl. 2018, 57, 5853–5857. [Google Scholar] [CrossRef]
  18. Meng, F.-J.; Shi, L.; Jiang, W.-F.; Lu, X.-B. Enantioselective 1,4-reduction of pyrimidin-2-ones to synthesize novel 3,4-dihydropyrimidin-2(1H)-ones Containing an Alkyl-substituted Stereogenic Center. Asian J. Org. Chem. 2020, 9, 778–781. [Google Scholar] [CrossRef]
  19. Ergan, E.; Akbas, E.; Levent, A.; Sahin, E.; Konus, M.; Seferoglu, N. Synthesis, theoretical calculation, electrochemistry and total antioxidant capacity of 5-benzoyl-6-phenyl-4-(4-methoxyphenyl)-1, 2, 3, 4-tetrahydro-2-thioxopyrimidine and derivatives. J. Mol. Struct. 2017, 1136, 231–243. [Google Scholar] [CrossRef]
  20. Díaz-Fernández, M.; Calvo-Losada, S.; Quirante, J.-J.; Sarabia, F.; Algarra, M.; Pino-González, M.-S. Catalyzed methods to synthesize pyrimidine and related heterocyclic compounds. Catalysts 2023, 13, 180. [Google Scholar] [CrossRef]
  21. Muñoz-Muñiz, O.; Juaristi, E. An enantioselective approach to the Biginelli dihydropyrimidinone condensation reaction using CeCl3 and InCl3 in the presence of chiral ligands. Arkivoc 2003, 11, 16–26. [Google Scholar] [CrossRef]
  22. Huang, Y.; Yang, F.; Zhu, C. Highly enantioseletive Biginelli reaction using a new chiral ytterbium catalyst:  Asymmetric synthesis of dihydropyrimidines. J. Am. Chem. Soc. 2005, 127, 16386–16387. [Google Scholar] [CrossRef]
  23. Chen, X.-H.; Xu, X.-Y.; Liu, H.; Cun, L.-F.; Gong, L.-Z. Highly enantioselective organocatalytic Biginelli reaction. J. Am. Chem. Soc. 2006, 128, 14802–14803. [Google Scholar] [CrossRef]
  24. Li, N.; Chen, X.-H.; Song, J.; Luo, S.-W.; Fan, W.; Gong, L.Z. Highly enantioselective organocatalytic Biginelli and Biginelli-like condensations: Reversal of the stereochemistry by tuning the 3,3′-disubstituents of phosphoric Acids. J. Am. Chem. Soc. 2009, 131, 15301–15310. [Google Scholar] [CrossRef]
  25. Bendi, A.; Bhathiwal, A.S.; Tiwari, A.; Rao, G.B.D.; Afshari, M. Precision in stereochemistry: The integral role of catalytic asymmetric Biginelli reaction in crafting enantiomerically pure dihydropyrimidinones. Mol. Divers. 2024. [Google Scholar] [CrossRef]
  26. Wu, X.; Gong, L.-Z. Chiral phosphoric acid-catalyzed asymmetric multicomponent reactions. In Multicomponent Reactions in Organic Synthesis; Ed. Wiley: Hoboken, NJ, USA, 2014; pp. 439–470. [Google Scholar]
  27. Li, N.; Chen, X.-H.; Zhou, S.-M.; Luo, S.-W.; Song, J.; Ren, L. Asymmetric amplification in phosphoric acid catalyzed reactions. Angew. Chem. Int. Ed. 2010, 49, 6378–6381. [Google Scholar] [CrossRef]
  28. Hu, X.; Zhang, R.; Xie, J.; Zhou, Z.; Shan, Z. Synthesis of a novel sterically hindered chiral cyclic phosphoric acid derived from L-tartaric acid and application to the asymmetric catalytic Biginelli reaction. Tetrahedron Asymmetry 2017, 28, 69–74. [Google Scholar] [CrossRef]
  29. Hu, X.; Guo, J.; Wang, C.; Zhang, R.; Borovkov, V. Stereoselective Biginelli-like reaction catalyzed by a chiral phosphoric acid bearing two hydroxy groups. Beilstein J. Org. Chem. 2020, 16, 1875–1880. [Google Scholar] [CrossRef]
  30. Guo, Y.; Gao, Z.; Meng, X.; Huang, G.; Zhong, H.; Yu, H.; Ding, X.; Tang, H.; Zou, C. Highly enantioselective Biginelli reaction of aliphatic aldehydes catalyzed by chiral phosphoric acids. Synlett 2017, 28, 2041–2045. [Google Scholar] [CrossRef]
  31. Guo, Y.; Gao, Z.; Fan, C.; Chen, J.; Li, J.; Huang, Y.; Huang, G.; Yu, H.; Zou, C. Enantioselective Biginelli reaction of aliphatic aldehydes catalyzed by a chiral phosphoric acid: A key step in the synthesis of the bicyclic guanidine core of Crambescin A and Batzelladine A. Synthesis 2018, 50, 2394–2406. [Google Scholar] [CrossRef]
  32. Arnold, M.A.; Day, K.A.; Durón, S.G.; Gin, D.Y. Total synthesis of (+)-Batzelladine A and (-)-Batzelladine D via [4 + 2]-annulation of vinyl carbodiimides with N-alkyl imines. J. Am. Chem. Soc. 2006, 128, 13255–13260. [Google Scholar] [CrossRef]
  33. Gao, Z.; Li, J.; Song, Y.; Bi, X.; Meng, X.; Guo, Y. Eight-step total synthesis of (+)-Crambescin A. RSC Adv. 2020, 10, 39266–39270. [Google Scholar] [CrossRef]
  34. Guo, Y.; Gao, Z.; Wang, K.; Li, J.; Bi, X.; Guo, L.; Liu, H.; Shi, E.; Xiao, J. Chiral spirocyclic phosphoric acid-catalyzed synthesis of 4-alkyl-3,4-dihydropyrimidin-2(1H)-one derivatives by asymmetric Biginelli reactions. Asian J. Org. Chem. 2020, 4, 626–630. [Google Scholar] [CrossRef]
  35. Hang, Z.; Dai, G.; Yu, H.; Han, S. Highly enantioselective synthesis of the 6-isopropyl-3,4-dihydropyrimidin-2-(1H)-thiones via asymmetric catalytic Biginelli reactions. Curr. Org. Chem. 2016, 20, 2917–2925. [Google Scholar] [CrossRef]
  36. Chetty, L.C.; Kruger, H.G.; Arvidsson, P.I.; Naicker, T.; Govender, T. Investigating the efficacy of green solvents and solvent-free conditions in hydrogen-bonding mediated organocatalyzed model reactions. RSC Adv. 2024, 14, 7992–7998. [Google Scholar] [CrossRef]
  37. Brandão, P.; Marques, C.; Burke, A.J.; Pineiro, M. The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules. Eur. J. Med. Chem. 2021, 211, 113102. [Google Scholar] [CrossRef] [PubMed]
  38. Stucchi, M.; Lesma, G.; Meneghetti, F.; Rainoldi, G.; Sacchetti, A.; Silvani, A. Organocatalytic asymmetric Biginelli-like reaction involving isatin. J. Org. Chem. 2016, 81, 1877–1884. [Google Scholar] [CrossRef] [PubMed]
  39. Maddela, S.; Makula, A.; Galigniana, M.D.; Parambi, D.G.; Federicci, F.; Mazaira, G.; Hendawy, O.M.; Dev, S.; Mathew, G.E.; Mathew, B. Fe3O4 nanoparticles mediated synthesis of novel spirooxindole-dihydropyrimidinone molecules as Hsp90 inhibitors. Arch. Der Pharm. 2019, 352, 1800174. [Google Scholar]
  40. Barbero, M.; Cadamuro, S.; Dughera, S. A Brønsted acid catalysed enantioselective Biginelli reaction. Green Chem. 2017, 19, 1529–1535. [Google Scholar] [CrossRef]
  41. Nasery, A.; Imanzadeh, G.; Zamanloo, M.R.; Soltanzadeh, Z.; Oztürk, T. Highly enantioselective Biginelli reaction using sulfonic-functionalized chiral hyperbranched polylysine in absence of solvent: A new catalyst for asymmetric synthesis of dihydropyrimidinones. Tetrahedron 2023, 147, 133656. [Google Scholar] [CrossRef]
  42. Chopda, L.V.; Dave, P.N. Recent advances in homogeneous and heterogeneous catalyst in Biginelli reaction from 2015–19: A Concise Review. ChemistrySelect 2020, 5, 5552–5572. [Google Scholar] [CrossRef]
  43. Alvim, H.G.O.; Pinheiro, D.L.J.; Carvalho-Silva, V.H.; Fioramonte, M.; Gozzo, F.C.; da Silva, W.A.; Amarante, G.W.; Neto, B.A. Combined role of the asymmetric counteranion-directed catalysis (ACDC) and ionic liquid effect for the enantioselective Biginelli multicomponent reaction. J. Org. Chem. 2018, 83, 12143–12153. [Google Scholar] [CrossRef]
  44. Deepa; Aalam, M.J.; Singh, S. Enantioselective Biginelli Reaction Catalyzed by (L)-Prolinamide Containing Imidazolium Ionic Liquid. ChemistrySelect 2022, 7, e202103918. [Google Scholar] [CrossRef]
  45. Xu, D.Z.; Li, H.; Wang, Y. Highly enantioselective Biginelli reaction catalyzed by a simple chiral primary amine catalyst: Asymmetric synthesis of dihydropyrimidines. Tetrahedron 2012, 68, 7867–7872. [Google Scholar] [CrossRef]
  46. Ding, D.; Zhao, C.-G. Primary amine catalyzed Biginelli reaction for the enantioselective synthesis of 3,4-dihydropyrimidin-2(1H)-ones. Eur. J. Org. Chem. 2010, 20, 3802–3805. [Google Scholar] [CrossRef] [PubMed]
  47. Lillo, V.J.; Mansilla, J.; Saá, J.M. Organocatalysis by networks of cooperative hydrogen bonds: Enantioselective direct Mannich addition to preformed arylideneureas. Angew. Chem. Int. Ed. 2016, 55, 4312–4316. [Google Scholar] [CrossRef]
  48. Lillo, V.J.; Saá, J.M. Towards enzyme-like, sustainable catalysis: Switchable, highly efficient asymmetric synthesis of enantiopure Biginelli dihydropyrimidinones or hexahydropyrimidinones. Chem. Eur. J. 2016, 22, 17182–17186. [Google Scholar] [CrossRef]
  49. Hatanaka, M.; Yoshimura, T.; Puripat, M.; Parasuk, V. Stereoselectivity of the Biginelli Reaction Catalyzed by Chiral Primary Amine: A Computational Study. Heterocycles 2021, 103, 893. [Google Scholar] [CrossRef]
  50. Titova, Y.; Fedorova, O.; Rusinov, G.; Vigorov, A.; Krasnov, V.; Murashkevich, A.; Charushin, V. Effect of nanosized TiO2-SiO2 covalently modified by chiral molecules on the asymmetric Biginelli reaction. Catal. Today 2015, 241 Pt B, 270–274. [Google Scholar] [CrossRef]
  51. Saha, S.; Moorthy, J.N. Enantioselective organocatalytic Biginelli reaction: Dependence of the catalyst on sterics, hydrogen bonding, and reinforced chirality. J. Org. Chem. 2011, 76, 396–402. [Google Scholar] [CrossRef]
  52. Fedorova, O.V.; Titova, Y.A.; Vigorov, A.Y.; Toporova, M.S.; Alisienok, O.A.; Murashkevich, A.N.; Krasnov, V.P.; Rusinov, G.L.; Charushin, V.N. Asymmetric Biginelli reaction catalyzed by silicon, titanium and aluminum oxides. Catal. Lett. 2016, 146, 493–498. [Google Scholar] [CrossRef]
  53. Yadav, G.D.; Deepa; Singh, S. Prolinamide-catalysed asymmetric organic transformations. ChemistrySelect 2019, 4, 5591–5618. [Google Scholar] [CrossRef]
  54. Titova, Y.A.; Gruzdev, D.A.; Fedorova, O.V.; Alisienok, O.A.; Murashkevich, A.N.; Krasnov, V.P.; Rusinov, G.L.; Charushin, V.N. New chiral proline-based catalysts for silicon and zirconium oxides-promoted asymmetric Biginelli reaction. Chem. Heter. Comp. 2018, 54, 417–427. [Google Scholar] [CrossRef]
  55. Fedorova, O.V.; Titova, Y.A.; Ovchinnikova, I.G.; Rusinov, G.L.; Charushin, V.N. 4-Hydroxyproline containing podands as new chiralcatalysts for the asymmetric Biginelli reaction. Mendeleev Commun. 2018, 28, 357–358. [Google Scholar] [CrossRef]
  56. Filatova, E.S.; Fedorova, O.V.; Ovchinnikova, I.G.; Chistyakov, K.A.; Ganebnykh, I.N.; Uimin, M.A.; Rusinov, G.L. Nanosized metal or silicon oxides and L-proline or 4-hydroxy-L-proline in stereoselective synthesis of a dihydropyrimidinethione podand. Appl. Organomet. Chem. 2023, 37, e7131. [Google Scholar] [CrossRef]
  57. Filatova, E.S.; Fedorova, O.V.; Ovchinnikova, I.G.; Chistyakov, K.A.; Rusinov, G.L.; Charushin, V.N. Stereoselective synthesis of dihydropyrimidinethione podand in the presence of l-proline or 4-hydroxy-l-proline and metal nitrates. Russ. Chem. Bull. 2022, 71, 1506–1513. [Google Scholar] [CrossRef]
  58. Koryakova, O.V.; Valova, M.S.; Titova, Y.A.; Murashkevich, A.N.; Fedorova, O.V. Synthesis and spectroscopic study of Si, Ti, Mg, and Zn oxides modified by L-proline. J. Appl. Spectrosc. 2021, 88, 519–527. [Google Scholar] [CrossRef]
  59. Borodina, O.; Ovchinnikova, I.; Fedorova, O.; Makarov, G.; Bartashevich, E. Effect of 4-Hydroxy-L-proline-containing podands on the stereoselectivity of Biginelli reaction according to molecular dynamics. Comp. Theor. Chem. 2022, 1217, 113885. [Google Scholar] [CrossRef]
  60. Filatova, E.S.; Fedorova, O.V.; Ovchinnikova, I.G.; Kochetkov, S.V.; Chistiakov, K.A.; Rusinov, G.L. Asymmetric synthesis of dihydropyrimidinethione podand in the presence of C2-Symmetric bis (Hydroxy) proline-containing amides. ChemistrySelect 2024, 9, e202401024. [Google Scholar] [CrossRef]
  61. Parvin, T.; Yadav, R.; Choudhury, L.H. Recent applications of thiourea-based organocatalysts in asymmetric multicomponent reactions (AMCRs). Org. Biomol. Chem. 2020, 18, 5513–5532. [Google Scholar] [CrossRef]
  62. Wang, Y.; Yu, J.; Miao, Z.; Chen, R. Bifunctional primary amine-thiourea-TfOH (BPAT·TfOH) as a chiral phase-transfer catalyst: The asymmetric synthesis of dihydropyrimidines. Org. Biomol. Chem. 2011, 9, 3050–3054. [Google Scholar] [CrossRef]
  63. Hang, Z.; Zhu, J.; Lian, X.; Xu, P.; Yu, H.; Han, S. A highly enantioselective Biginelli reaction using self-assembled methanoproline thiourea organocatalysts: Asymmetric synthesis of 6-isopropyl-3,4-dihydropyrimidines. Chem. Commun. 2016, 52, 80–83. [Google Scholar] [CrossRef]
  64. Yu, H.; Xu, P.; He, H.; Zhu, J.; Lin, H.; Han, S. Highly enantioselective Biginelli reactions using methanopyroline/thiourea-based dual organocatalyst systems: Asymmetric synthesis of 4-substituted unsaturated aryl dihydropyrimidines. Tetrahedron Asymmetry 2017, 28, 257–265. [Google Scholar] [CrossRef]
  65. Kamali, M. Asymmetric synthesis of dihydropyrimidines using chiral Schiff base copper (II) complex as a chiral catalyst. Int. J. Chem. Technol. 2015, 8, 536–541. [Google Scholar]
  66. Lakhani, P.; Chodvadiya, D.; Jha, P.K.; Gupta, V.K.; Trzybinski, D.; Wozniak, K.; Kurzydlowski, K.; Goutam, U.K.; Srivastava, H.; Modi, C.K. DFT stimulation and experimental insights of chiral Cu(II)-salen scaffold within the pocket of MWW-zeolite and its catalytic study. Phys. Chem. Chem. Phys. 2023, 25, 14374–14386. [Google Scholar] [CrossRef]
  67. Matharasi, D.P.; Jayaprakash, P. An extensive investigation of structural, spectral, optical, electrical, and nonlinear optical properties of a novel crystal (S) 4-(5-bromo-2-acyloxy phenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid ethyl ester. Opt. Mater. 2023, 141, 113911. [Google Scholar] [CrossRef]
  68. Sharma, U.K.; Sharma, N.; Kumar, R.; Sinha, A.K. Biocatalysts for multicomponent Biginelli reaction: Bovine serum albumin triggered waste-free synthesis of 3,4-dihydropyrimidin-2-(1H)-ones. Amino Acids 2013, 44, 1031–1037. [Google Scholar] [CrossRef]
  69. Elkanzi, N.A.A.; Kadry, A.M.; Ryad, R.M.; Bakr, R.B.; El-Remaily, M.A.E.A.A.A.; Ali, A.M. Efficient and recoverable bio-organic catalyst cysteine for synthesis, docking study, and antifungal activity of new bio-active 3,4-dihydropyrimidin-2(1H)-ones/thiones under microwave irradiation. ACS Omega 2022, 7, 22839–22849. [Google Scholar] [CrossRef]
  70. Parmar, M.P.; Vala, D.P.; Bhalodiya, S.S.; Upadhyay, D.B.; Patel, C.D.; Patel, S.G.; Gandholi, S.R.; Shaik, A.H.; Miller, A.D.; Nogales, J.; et al. A green bio-organic catalyst (taurine) promoted one-pot synthesis of (R/S)-2-thioxo-3,4-dihydropyrimidine (TDHPM)-5-carboxanilides: Chiral investigations using circular dichroism and validation by computational approaches. RSC Adv. 2024, 14, 9300–9313. [Google Scholar] [CrossRef]
  71. Figueiredo, J.A.; Ismael, M.I.; Pinheiro, J.M.; Silva, A.M.S.; Justino, J.; Silva, F.V.M.; Goulart, M.; Mira, D.; Araújo, M.E.M.; Campoy, R.; et al. Facile synthesis of oxo-/thioxopyrimidines and tetrazoles C–C linked to sugars as novel non-toxic antioxidant acetylcholinesterase inhibitors. Carbohydr. Res. 2012, 347, 47–54. [Google Scholar] [CrossRef] [PubMed]
  72. Venturi, V.; Marchesi, E.; Perrone, D.; Costa, V.; Catani, M.; Aprile, S.; Lerin, L.A.; Zappaterra, F.; Giovannini, P.P.; Preti, L. Enzymatic synthesis of New Acetoacetate–Ursodeoxycholic Acid Hybrids as potential therapeutic agents and useful synthetic scaffolds as well. Molecules 2024, 29, 1305. [Google Scholar] [CrossRef] [PubMed]
  73. Dias Benincá, L.A.; Pereira Ligiero, C.B.; da Silva Santos, J.; Junior, J.J.; da Silva, F.M. Eco-friendly and enantiospecific Biginelli synthesis using (+)-Myrtenal as the substrate–An impeccable and unequivocal analysis of the product. Curr. Org. Chem. 2020, 17, 389–395. [Google Scholar] [CrossRef] [PubMed]
  74. Jafari-Chermahini, M.T.; Tavakol, H. Immobilized gelatin–λ–carrageenan on magnetite nanoparticles as an efficient organocatalyst for enantioselective Biginelli reaction. ChemistrySelect 2019, 4, 1895–1902. [Google Scholar] [CrossRef]
  75. Yu, S.; Wu, J.; Lan, H.; Gao, L.; Qian, H.; Fan, K.; Yin, Z. Palladium and Brønsted acid co-catalyzed Biginelli-like multicomponent reactions via in situ-generated cyclic enol ether: Access to spirofuran-hydropyrimidinones. Org. Lett. 2019, 22, 102–105. [Google Scholar] [CrossRef]
  76. Krauskopf, F.; Truong, K.-N.; Rissanen, K.; Bolm, C. 2,3-Dihydro-1,2,6-thiadiazine 1-oxides by Biginelli-type reactions with sulfonimidamides under mechanochemical conditions. Org. Lett. 2021, 23, 2699–2703. [Google Scholar] [CrossRef] [PubMed]
Molecules 29 03864 sch001
Scheme 1. Asymmetric Biginelli reaction with cat Ia.
Scheme 1. Asymmetric Biginelli reaction with cat Ia.
Molecules 29 03864 sch001
Molecules 29 03864 sch002
Scheme 2. Comparative results with cat Ia or cat Ib and proposed chiral transition-state structure with cat Ia.
Scheme 2. Comparative results with cat Ia or cat Ib and proposed chiral transition-state structure with cat Ia.
Molecules 29 03864 sch002
Molecules 29 03864 sch003
Scheme 3. Asymmetric Biginelli reaction with cat II.
Scheme 3. Asymmetric Biginelli reaction with cat II.
Molecules 29 03864 sch003
Molecules 29 03864 g001
Figure 1. Structures of cat II, Crambescin A, and Batzelladine A.
Figure 1. Structures of cat II, Crambescin A, and Batzelladine A.
Molecules 29 03864 g001
Molecules 29 03864 sch004
Scheme 4. Asymmetric Biginelli reaction with cat III.
Scheme 4. Asymmetric Biginelli reaction with cat III.
Molecules 29 03864 sch004
Molecules 29 03864 sch005
Scheme 5. Synthesis formal of (+)-Batzelladine A by Biginelli reaction with cat III.
Scheme 5. Synthesis formal of (+)-Batzelladine A by Biginelli reaction with cat III.
Molecules 29 03864 sch005
Molecules 29 03864 sch006
Scheme 6. Asymmetric Biginelli reactions with cat IV.
Scheme 6. Asymmetric Biginelli reactions with cat IV.
Molecules 29 03864 sch006
Molecules 29 03864 sch007
Scheme 7. Synthesis of spiro(indoline-pyrimidine) dione derivatives 13.
Scheme 7. Synthesis of spiro(indoline-pyrimidine) dione derivatives 13.
Molecules 29 03864 sch007
Molecules 29 03864 sch008
Scheme 8. Synthesis and proposed mechanism for the enantioselective formation of DHPMs 4.
Scheme 8. Synthesis and proposed mechanism for the enantioselective formation of DHPMs 4.
Molecules 29 03864 sch008
Molecules 29 03864 g002
Figure 2. Sulfonic-functionalized hyperbranched polylysine (HBPL-SO3H) (cat VI).
Figure 2. Sulfonic-functionalized hyperbranched polylysine (HBPL-SO3H) (cat VI).
Molecules 29 03864 g002
Molecules 29 03864 sch009
Scheme 9. The proposed mechanism for the Biginelli reaction in the presence of the catalyst HBPL-SO3H (cat VI).
Scheme 9. The proposed mechanism for the Biginelli reaction in the presence of the catalyst HBPL-SO3H (cat VI).
Molecules 29 03864 sch009
Molecules 29 03864 sch010
Scheme 10. Combined catalyst MSI-(R)-TRIP (cat VII) in an ABR.
Scheme 10. Combined catalyst MSI-(R)-TRIP (cat VII) in an ABR.
Molecules 29 03864 sch010
Molecules 29 03864 sch011
Scheme 11. ABR with cat VIII and plausible transition state (TS-I) to favor re-face attack.
Scheme 11. ABR with cat VIII and plausible transition state (TS-I) to favor re-face attack.
Molecules 29 03864 sch011
Molecules 29 03864 sch012
Scheme 12. Enantioselective synthesis of DHPMs (R)-4a from alkylidene ureas with cat (R,R)-IX.
Scheme 12. Enantioselective synthesis of DHPMs (R)-4a from alkylidene ureas with cat (R,R)-IX.
Molecules 29 03864 sch012
Molecules 29 03864 g003
Figure 3. Transition state for cat (S,S)-IX by a network of cooperative hydrogen bonds (NCHB) in the synthesis of the DHPMs (S)-4a.
Figure 3. Transition state for cat (S,S)-IX by a network of cooperative hydrogen bonds (NCHB) in the synthesis of the DHPMs (S)-4a.
Molecules 29 03864 g003
Molecules 29 03864 sch013
Scheme 13. Synthesis of the HHPMs 16 by an ABR catalyzed by cat (R,R)-IX.
Scheme 13. Synthesis of the HHPMs 16 by an ABR catalyzed by cat (R,R)-IX.
Molecules 29 03864 sch013
Molecules 29 03864 g004
Figure 4. The catalyst cat X used by Saha and Moorthy in the ABR [51].
Figure 4. The catalyst cat X used by Saha and Moorthy in the ABR [51].
Molecules 29 03864 g004
Molecules 29 03864 sch014
Scheme 14. Synthesis of chirally modified TiO2·SiO2 nanoparticles containing (3-aminopropyl)triethoxysilane.
Scheme 14. Synthesis of chirally modified TiO2·SiO2 nanoparticles containing (3-aminopropyl)triethoxysilane.
Molecules 29 03864 sch014
Molecules 29 03864 sch015
Scheme 15. Asymmetric catalyzed reaction with chiral proline derivative and metal oxides.
Scheme 15. Asymmetric catalyzed reaction with chiral proline derivative and metal oxides.
Molecules 29 03864 sch015
Molecules 29 03864 g005
Figure 5. Prolinamides used alone or in combination with nanosized oxides in an ABR.
Figure 5. Prolinamides used alone or in combination with nanosized oxides in an ABR.
Molecules 29 03864 g005
Molecules 29 03864 g006
Figure 6. Prolinamides with a polyether spacer used as catalysts.
Figure 6. Prolinamides with a polyether spacer used as catalysts.
Molecules 29 03864 g006
Molecules 29 03864 g007
Figure 7. A dihydropyrimidinethione-containing podand (R,R)-17 obtained by ABR.
Figure 7. A dihydropyrimidinethione-containing podand (R,R)-17 obtained by ABR.
Molecules 29 03864 g007
Molecules 29 03864 g008
Figure 8. Complexation of the podand 18 with metal ion in the transition state of ABR with iminium ions and hydroxy prolines.
Figure 8. Complexation of the podand 18 with metal ion in the transition state of ABR with iminium ions and hydroxy prolines.
Molecules 29 03864 g008
Molecules 29 03864 sch016
Scheme 16. Synthesis of the podand DHPTs (R,R)-17 and (S,S)-17.
Scheme 16. Synthesis of the podand DHPTs (R,R)-17 and (S,S)-17.
Molecules 29 03864 sch016
Molecules 29 03864 sch017
Scheme 17. Synthesis of the DHPTs 22 with the combined cat XX of proline/thiourea.
Scheme 17. Synthesis of the DHPTs 22 with the combined cat XX of proline/thiourea.
Molecules 29 03864 sch017
Molecules 29 03864 sch018
Scheme 18. Plausible reaction mechanism for an ABR with the combined cat XX of proline/thiourea.
Scheme 18. Plausible reaction mechanism for an ABR with the combined cat XX of proline/thiourea.
Molecules 29 03864 sch018
Molecules 29 03864 sch019
Scheme 19. Synthesis of the DHPTs 21 with a chiral Cu (II) complex (cat XXI).
Scheme 19. Synthesis of the DHPTs 21 with a chiral Cu (II) complex (cat XXI).
Molecules 29 03864 sch019
Molecules 29 03864 sch020
Scheme 20. ABR catalyzed by an encapsulated chiral Cu(II) salen catalyst (cat XXII).
Scheme 20. ABR catalyzed by an encapsulated chiral Cu(II) salen catalyst (cat XXII).
Molecules 29 03864 sch020
Molecules 29 03864 sch021
Scheme 21. Synthesis of the DHPM 26 with cat XXIII.
Scheme 21. Synthesis of the DHPM 26 with cat XXIII.
Molecules 29 03864 sch021
Molecules 29 03864 sch022
Scheme 22. Synthesis of the DHPM 28 in the presence of cysteine.
Scheme 22. Synthesis of the DHPM 28 in the presence of cysteine.
Molecules 29 03864 sch022
Molecules 29 03864 sch023
Scheme 23. Synthesis of racemic (R,S)-30 in the presence of taurine and their chiral resolution by HPLC.
Scheme 23. Synthesis of racemic (R,S)-30 in the presence of taurine and their chiral resolution by HPLC.
Molecules 29 03864 sch023
Molecules 29 03864 sch024
Scheme 24. Synthesis of ursodeoxycholic-derived 32a, 32b.
Scheme 24. Synthesis of ursodeoxycholic-derived 32a, 32b.
Molecules 29 03864 sch024
Molecules 29 03864 sch025
Scheme 25. Synthesis of myrtenal derivative (R)-33.
Scheme 25. Synthesis of myrtenal derivative (R)-33.
Molecules 29 03864 sch025
Molecules 29 03864 sch026
Scheme 26. Synthesis of the spirofuran-hydropyrimidinone or -hydropyrimidinethione compounds 35.
Scheme 26. Synthesis of the spirofuran-hydropyrimidinone or -hydropyrimidinethione compounds 35.
Molecules 29 03864 sch026
Molecules 29 03864 sch027
Scheme 27. Synthesis of the 2,3-dihydro-1,2,6-thiadiazine 1-oxides 37 from the sulfonimidamides 36.
Scheme 27. Synthesis of the 2,3-dihydro-1,2,6-thiadiazine 1-oxides 37 from the sulfonimidamides 36.
Molecules 29 03864 sch027
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Díaz-Fernández, M.; Algarra, M.; Calvo-Losada, S.; Quirante, J.-J.; Sarabia, F.; Pino-González, M.-S. Diverse Methods with Stereoselective Induction in the Asymmetric Biginelli Reaction. Molecules 2024, 29, 3864. https://doi.org/10.3390/molecules29163864

AMA Style

Díaz-Fernández M, Algarra M, Calvo-Losada S, Quirante J-J, Sarabia F, Pino-González M-S. Diverse Methods with Stereoselective Induction in the Asymmetric Biginelli Reaction. Molecules. 2024; 29(16):3864. https://doi.org/10.3390/molecules29163864

Chicago/Turabian Style

Díaz-Fernández, Marcos, Manuel Algarra, Saturnino Calvo-Losada, José-Joaquín Quirante, Francisco Sarabia, and María-Soledad Pino-González. 2024. "Diverse Methods with Stereoselective Induction in the Asymmetric Biginelli Reaction" Molecules 29, no. 16: 3864. https://doi.org/10.3390/molecules29163864

Article Metrics

Back to TopTop